You just read:

Gliknik Announces Dosing Of First Patient In Phase 2 Trial Targeting Prevention Of Recurrence Of High-Risk Oral Cavity Cancer

News provided by

Gliknik Inc.

Aug 28, 2017, 13:00 ET